5 Insightful Analyst Questions From Knowles's Q4 Earnings Call

Knowles delivered a positive Q4, with revenue growth fueled by broad-based demand across its Precision Devices and Medtech & Specialty Audio segments. Management attributed the results to normalized channel inventories and new design wins in high-growth markets such as medical, defense, and energy. CEO Jeffrey Niew emphasized the company’s ability to leverage custom-engineered solutions and close customer relationships to secure next-generation projects. He pointed to strong bookings and a healthy backlog, noting, “Our customers continue to choose our innovative and differentiated solutions, resulting in a robust pipeline of new design wins.”

Is now the time to buy KN? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Knowles’s Q4 Earnings Call

• Christopher Rolland (Susquehanna) asked about the breadth of new customers for the specialty film product and timing for capacity additions. CEO Jeffrey Niew detailed a broadening customer base and confirmed expectations for the energy order to ramp fully by the end of Q2.
• Rolland (Susquehanna) also pressed on organic versus acquisition-driven growth. Niew replied that while acquisition opportunities exist, organic growth prospects—especially in medical and energy—appear promising for the next 24–36 months.
• Anthony Stoss (Craig Hallum) inquired about gross margin dynamics for the coming quarters. CFO John Anderson said margins should rise in the back half of 2026 as specialty film volumes ramp and efficiencies are realized, though specific quarterly guidance was not provided.
• Stoss (Craig Hallum) questioned which markets will lead growth in 2026. Niew emphasized broad-based strength, with energy and industrial segments showing the most notable momentum recently, in addition to ongoing defense and medtech demand.
• Robert Labick (CJS Securities) sought clarity on the status and flexibility of the new specialty film capacity. Niew explained the Greenville facility is being set up for both high-volume and higher-mix production, enabling flexible response to evolving customer requirements.

Catalysts in Upcoming Quarters

Over the next few quarters, our analysts will be watching (1) the successful ramp of specialty film production for the large energy order, (2) evidence of sustained design win momentum in medical and defense applications, and (3) the company’s ability to maintain or expand margins as capacity utilization increases. The pace of adoption in new industrial applications and management’s execution on capacity expansion will also be important indicators of ongoing progress.

Knowles currently trades at $27.00, up from $24.74 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).

Our Favorite Stocks Right Now

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.